| Literature DB >> 35334973 |
Olga Papagianni1, Eleni Delli1, Melina-Eleni Vasila1, Thomas Loukas2, Athanasios Magkoutis2, Charalampia Dimou1, Haralampos C Karantonis3, Antonios E Koutelidakis1.
Abstract
Several fruit by-products may exert a beneficial role on oxidative stress and inflammation modulation, providing essential bioactive components, such as polyphenols and carotenoids. Recently, the potential bioactivity of miso has been reported. The aim of this dietary intervention-clinical study was to evaluate the acute effect of a novel, functional miso-type sauce based on legumes, on postprandial biomarkers of oxidative stress and inflammation. In this randomized, cross-over design, intervention-clinical trial, 14 healthy volunteers, aged 20-30 years old, consumed a rice meal rich in fat and carbohydrates (258 g), containing a legume-based sauce. After a 1-week washout period, the same subjects consumed the same meal, containing the novel fermented miso-type sauce, enhanced with 50% carotenoid-rich, fruit peel extract. Differences in postprandial total plasma antioxidant capacity according to the FRAP method, serum lipids, glucose, uric acid levels, and antithrombotic activity in platelet-rich plasma were evaluated before, 30 min, 1.5 h, and 3 h after consumption. The results showed that, in comparison to the control group, consumption of the novel sauce resulted in a significantly increased total plasma antioxidant capacity 3 h after consumption (p < 0.05). In addition, we observed a significant attenuation of triglycerides concentration increase in the last 1.5 h in the functional group (p < 0.05). A significant decrease in serum aggregation was found at 30 min and 3 h after functional sauce intake in comparison with the baseline (p < 0.05). Finally, LDL-cholesterol concentrations were significantly reduced 3 h after the functional meal consumption, in comparison with baseline values (p < 0.05). The remaining biomarkers did not show statistically significant differences (p > 0.05). Further investigation is needed in order to validate the current results.Entities:
Keywords: bioactive components; carotenoid-rich extract; fruit by-products; functional sauce; metabolic biomarkers; novel miso-type sauce; postprandial bioactivity
Mesh:
Substances:
Year: 2022 PMID: 35334973 PMCID: PMC8954115 DOI: 10.3390/nu14061316
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1(a) Control meal; (b) functional meal, before consumption.
Nutritional value of the experimental meals (each meal).
| Meals’ Nutritional Value | ||
|---|---|---|
| Control | Functional | |
| Energy (kcal) | 932.155 | 932.155 |
| Carbohydrates (g) | 140.945 | 140.945 |
| Fat, total (g) | 29.972 | 29.972 |
| Protein (g) | 29.295 | 29.298 |
| Saturated fat (g) | 17.6935 | 17.6935 |
| Unsaturated fat (g) | 8.6685 | 8.6685 |
| Cholesterol (mg) | 73.6 | 73.6 |
| Dietary fiber, total (g) | 4.6 | 4.6 |
| Sugar, total (g) | 0.845 | 0.845 |
| Total phenolics (mg/g) | 0 | 57.6 |
| Total carotenoids (mg/g) | 0 | 48.16 |
| Total antioxidants (mmol/g) | 0 | 165.18 |
Figure 2Study design illustration.
The baseline characteristics of participants.
| Variable | |
|---|---|
| General Characteristics | N |
| Volunteers | 14 |
| Men | 6 |
| Women | 8 |
| Smoking | 4 |
| Physical Activity | |
| Low | 2 |
| Medium | 6 |
| High | 6 |
| Mean ± SD | |
| Age (years) | 23.5 ± 2.7 a |
| Anthropometry and Body Composition | |
| Weight (kg) | 71.5 ± 15.3 b |
| Height (cm) | 170.1 ± 8.1 c |
| BMI | 24.5 ± 3.5 d |
| Fat mass (kg) | 20.9 ± 7 |
| Muscle mass (kg) | 53.4 ± 11.1 |
| Body water (kg) | 55 ± 6.8 |
| Bone mass (kg) | 2.8 ± 0.3 |
| Waist/hip circumference ratio | 0.7 ± 0.17 |
Different letters indicate statistical signifficant differences.
Figure 3(a) Incremental changes in postprandial plasma total antioxidant capacity (TAC). (b) The incremental area under the curve (iAUC) for postprandial plasma TAC.
Figure 4(a) Incremental changes in postprandial serum triglycerides (TG) concentration. (b) The incremental area under the curve (iAUC) for postprandial serum TG.
Figure 5(a) Incremental changes in aggregation in PRP (cm). (b) The incremental area under the curve (iAUC) for aggregation in PRP (cm × h).
Figure 6(a) Incremental changes in postprandial total cholesterol concentration. (b) Incremental changes in postprandial HDL-cholesterol concentration. (c) Incremental changes in postprandial LDL-cholesterol concentration. (d) Incremental changes in postprandial serum glucose concentration. (e) Incremental changes in postprandial uric acid concentration.
Postprandial responses of serum lipids, glucose, aggregation, and plasma TAC, following a high-carbohydrate and fat meal, containing a novel miso-type or a control sauce.
| Control | Functional | |
|---|---|---|
| Total cholesterol at baseline (mg/dL) | 170.53 ± 34.5 | 145.15 ± 33.2 |
| Δ 30 min | −0.61 ± 0.43 | 10.53 ± 7.45 |
| Δ 1.5 h | −10.28 ± 7.27 | −10.3 ± 7.28 |
| Δ 3 h | 3.16 ± 2.23 | 2.07 ± 2.17 |
| iAUC | 408.9 ± 180.78 | 446.16 ± 81.15 |
| Glucose at baseline (mg/dL) | 87.9 ± 10.77 | 91.07 ± 19.2 |
| Δ 30 min | 13.18 ± 9.32 | 13.38 ± 9.46 |
| Δ 1.5 h | −18.18 ± 12.85 | −21.37 ± 15.11 |
| Δ 3 h | 0.9 ± 0.64 | −3.91 ± 2.76 |
| iAUC | 262.13 ± 37.7 | 246.7 ± 66.59 |
| Triglycerides at baseline (mg/dL) | 111.61 ± 44.48 | 98.76 ± 29.4 |
| Δ 30 min | 7.84 ± 5.54 | 21.61 ± 15.28 |
| Δ 1.5 h | 5.92 ± 4.18 | −3.07 ± 2.17 |
| Δ 3 h | −12.5 ± 8.86 | −20.9 ± 10.55 |
| iAUC | 412.61 ± 152.08 | 298.27 ± 112.07 |
| HDL-cholesterol at baseline (mg/dL) | 98.12 ± 28.78 | 98.57 ± 31.36 |
| Δ 30 min | −0.76 ± 0.47 | 21.61 ± 15.28 |
| Δ 1.5 h | 0.13 ± 0.09 | −3.07 ± 2.17 |
| Δ 3 h | −10.37 ± 7.33 | −17.9 ± 10.55 |
| iAUC | 270.61 ± 100,47 | 276.68 ± 97.71 |
| LDL-cholesterol at baseline (mg/dL) | 129.16 ± 24.11 | 145.36 ± 25.91 |
| Δ 30 min | 18.64 ± 13.18 | −12.72 ± 8.99 |
| Δ 1.5 h | −18.68 ± 13.21 | −0.41 ± 0.29 |
| Δ 3 h | 12.73 ± 9 | −9.89 ± 6.22 |
| iAUC | 422.18 ± 39.36 | 432.65 ± 57.76 |
| Uric acid at baseline (mg/dL) | 5.68 ± 1.37 | 5.44 ± 1.84 |
| Δ 30 min | −0.88 ± 0.62 | 0.33 ± 0.23 |
| Δ 1.5 h | 0.19 ± 0.13 | −0.35 ± 0.24 |
| Δ 3 h | −0.33 ± 0.23 | −0.9 ± 0.65 |
| iAUC | 14.74 ± 5.48 | 15.47 ± 4.54 |
| Total plasma antioxidant capacity (TAC) (mmol/L) | 0.93 ± 0.31 | 0.91 ± 0.74 |
| Δ 30 min | 0.23 ± 0.16 | 0.18 ± 0.12 |
| Δ 1.5 h | −0.55 ± 0.32 | −0.27 ± 0.19 |
| Δ 3 h | −0.09 ± 0 | 0.7 ± 0.42 |
| iAUC | 2.06 ± 0.69 | 3.46 ± 1.69 |
| Aggregation in PRP (cm) | 10.01 ± 3.3 | 0.82 ± 4.18 |
| Δ 30 min | 0.05 ± 0.03 | −2.55 ± 1.8 |
| Δ 1.5 h | −1.37 ± 0.97 | 1.82 ± 1.29 |
| Δ 3 h | −0.02 ± 0.06 | −2.7 ± 1.2 |
| iAUC | 29 ± 6.08 | 23.98 ± 7.87 |